Download PDF
1
/
Pages
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence of atherogenic dyslipidemia, related factors and level of lipid control in the general population of Galicia. GALIPEMIAS study
Carlos Názara; Rosa M. Argüeso; Juan Pedro-Botet; Xavier Pintó; Jesús Millán; Marta Pena Seijo; Pablo A. Fernández; M. Eugenia Ameneiros; Alberto del Alamo; Avelino Rodríguez; José Antonio Díaz-Peromingo; María Rosa Vázquez Freire; Javier Muñiz; Teresa R. Pérez-Castro; José Luis Díaz-Díaz; Antonio Pose Reino;
Clin Investig Arterioscler. 2023;35:178-84
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;
Clin Investig Arterioscler. 2023;35:263-71
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study
Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;
Clin Investig Arterioscler. 2023;35:272-9